当前位置:首页 - 行情中心 - 特宝生物(688278) - 财务分析 - 现金流量表

特宝生物

(688278)

  

流通市值:349.28亿  总市值:349.28亿
流通股本:4.07亿   总股本:4.07亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,609,290,713.9806,382,960.162,542,432,982.681,895,427,035.95
  收到的税费返还1.4-813,528.94813,532.12
  收到其他与经营活动有关的现金20,440,741.7814,936,533.532,116,332.1126,558,301.84
  经营活动现金流入小计1,629,731,457.08821,319,493.662,575,362,843.731,922,798,869.91
  购买商品、接受劳务支付的现金88,983,339.7737,915,914.43152,996,440.57116,037,296.12
  支付给职工以及为职工支付的现金450,478,475.84251,792,654.35739,657,133.79570,382,289.79
  支付的各项税费142,204,355.1871,759,296.32229,631,677.74174,193,161.47
  支付其他与经营活动有关的现金587,519,873.82253,111,450.761,022,444,413.21770,171,078.2
  经营活动现金流出小计1,269,186,044.61614,579,315.862,144,729,665.311,630,783,825.58
  经营活动产生的现金流量净额360,545,412.47206,740,177.8430,633,178.42292,015,044.33
二、投资活动产生的现金流量:
  收回投资收到的现金846,874,667.36581,340,103.53639,120,894.38548,428,709.76
  处置固定资产、无形资产和其他长期资产收回的现金净额21,30014,00027,809.3254,090
  投资活动现金流入小计846,895,967.36581,354,103.53639,148,703.7548,482,799.76
  购建固定资产、无形资产和其他长期资产支付的现金98,678,266.4459,717,400.69251,353,307.5190,403,534.86
  投资支付的现金695,000,000570,000,000696,412,200558,412,200
  投资活动现金流出小计793,678,266.44629,717,400.69947,765,507.5748,815,734.86
  投资活动产生的现金流量净额53,217,700.92-48,363,297.16-308,616,803.8-200,332,935.1
三、筹资活动产生的现金流量:
  取得借款收到的现金10,000,00010,000,000--
  筹资活动现金流入平衡项目00--
  筹资活动现金流入小计10,000,00010,000,000--
  分配股利、利润或偿付利息支付的现金252,362,208.33146,208.33166,788,000166,788,000
  支付其他与筹资活动有关的现金4,420,102.392,044,881.96,228,998.144,583,528.22
  筹资活动现金流出小计256,782,310.722,191,090.23173,016,998.14171,371,528.22
  筹资活动产生的现金流量净额-246,782,310.727,808,909.77-173,016,998.14-171,371,528.22
四、汇率变动对现金及现金等价物的影响170,763.6364,915.87-134,623.31-11,358.53
五、现金及现金等价物净增加额167,151,566.3166,250,706.28-51,135,246.83-79,700,777.52
  加:期初现金及现金等价物余额361,515,698.43361,515,698.43412,650,945.26412,650,945.26
  期末现金及现金等价物余额528,667,264.73527,766,404.71361,515,698.43332,950,167.74
补充资料:
  净利润427,894,111.21-827,602,233.89-
  固定资产和投资性房地产折旧23,156,309.38-32,993,731.87-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧23,156,309.38-32,993,731.87-
  无形资产摊销20,423,225.35-36,036,331.97-
  长期待摊费用摊销6,166,068.79-18,082,042.93-
  处置固定资产、无形资产和其他长期资产的损失-21,300--65,368.15-
  固定资产报废损失242,604.15-92,286.92-
  公允价值变动损失-590,535.23--882,868.15-
  财务费用209,203.06-587,305.32-
  投资损失-1,873,297.19--4,053,394.38-
  递延所得税-3,070,583.72--24,899,123.74-
  其中:递延所得税资产减少-3,121,936.16--25,427,873.64-
    递延所得税负债增加51,352.44-528,749.9-
  存货的减少-57,645,754.59--76,528,701.77-
  经营性应收项目的减少4,504,566.2--404,826,737.45-
  经营性应付项目的增加-87,684,247.3-453,232.52-
  其他26,392,458.89-16,100,715.14-
  现金的期末余额528,667,264.73-361,515,698.43-
  减:现金的期初余额361,515,698.43-412,650,945.26-
  现金及现金等价物的净增加额167,151,566.3--51,135,246.83-
公告日期2025-08-212025-04-232025-03-282024-10-25
审计意见(境内)标准无保留意见
TOP↑